Abstract
Chronic restrictive lung disease in a 9-year-old boy with dyskeratosis congenita (DC) 7 years after allogeneic bone marrow transplantation (BMT) is described. When he was 1 year and 10 months old, severe aplastic anemia developed. He received a marrow transplant from his HLA serologically identical, but HLA-DP mismatched brother. He developed grade II acute graft-versus-host disease (GVHD) and thereafter chronic GVHD of progressive type, and was treated with both prednisolone and azathioprine resulting in clinical improvement. Thereafter he complained of dyspnea, and bilateral noncircumscribed interstitial shadows on chest CT scan were present. His pulmonary function showed restrictive changes. Prednisolone was not effective and he died of respiratory failure. Post-mortem examination confirmed interstitial fibrosis, lymphocytic infiltration of the bronchioles and alveoli with luminal fibrosis. There was no evidence of chronic GVHD in the skin and the liver. These findings raise the possibility that this pulmonary complication was associated with DC itself.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yabe, M., Yabe, H., Hattori, K. et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant 19, 389–392 (1997). https://doi.org/10.1038/sj.bmt.1700674
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700674
Keywords
This article is cited by
-
Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review
BMC Pulmonary Medicine (2021)
-
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure
Bone Marrow Transplantation (2013)
-
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita
Bone Marrow Transplantation (2012)
-
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review
BMC Blood Disorders (2011)
-
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita
Bone Marrow Transplantation (2011)